Structural basis of selective cannabinoid CB(2) receptor activation

Cannabinoid CB(2) receptor (CB(2)R) agonists are investigated as therapeutic agents in the clinic. However, their molecular mode-of-action is not fully understood. Here, we report the discovery of LEI-102, a CB(2)R agonist, used in conjunction with three other CBR ligands (APD371, HU308, and CP55,94...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoting, Chang, Hao, Bouma, Jara, de Paus, Laura V., Mukhopadhyay, Partha, Paloczi, Janos, Mustafa, Mohammed, van der Horst, Cas, Kumar, Sanjay Sunil, Wu, Lijie, Yu, Yanan, van den Berg, Richard J. B. H. N., Janssen, Antonius P. A., Lichtman, Aron, Liu, Zhi-Jie, Pacher, Pal, van der Stelt, Mario, Heitman, Laura H., Hua, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017709/
https://www.ncbi.nlm.nih.gov/pubmed/36922494
http://dx.doi.org/10.1038/s41467-023-37112-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017709/
https://www.ncbi.nlm.nih.gov/pubmed/36922494
http://dx.doi.org/10.1038/s41467-023-37112-9

Ejemplares similares